Green M, Rankin A, Gerard G F, Grandgenett D P, Green M R
J Natl Cancer Inst. 1975 Aug;55(2):433-42.
At concentrations of 7 times 10(-6) to 7 times 10(-5) M, derivatives consisting of the polycylic ring structures fluoranthene, fluorenone, fluorene, anthraquinone, xanthenone, and dibenzofuran with appropriate amine side chains inhibited by over 90% the purified RNA-directed DNA polymerase of avian myeloblastosis virus acting on poly(deoxyadenylate-deoxythymidylate) [poly(dA-dT)]. Of these, only the fluoranthene derivatives were strong inhibitors of the viral DNA polymerase directed by polyadenylate-oligodeoxythymidylate [poly(A)-(dT)12-18]. Low levels of fluoranthene derivatives (1 times 10(-5) M) also strongly inhibited polymerase with polyinosinate-oligodeoxycytidylate [poly(I)-(dC)12-18], activated calf thymus DNA, and viral 70S RNA as templates, but not with polycytidylate-oligodeoxyguanylate as template. A comparison of the activity of 11 fluoranthene derivatives with different side chains showed that the structure of the amine side chain influenced both the extent of antipolymerase activity with a given template and the relative inhibition with different synthetic DNA and RNA templates. The naturally occurring polyamines, spermine, spermidine, and putrescine, did not inhibit the activity of the viral DNA polymerase. Studies on the mechanism of action indicated that the synthetic derivatives inhibited polymerase activity by binding to the template and not to the enzyme: 1) inhibition by fluoranthene derivatives was overcome by the addition of excess template including poly(dA-dT), poly(A)-(dT)12-18, poly(I)-(dC)12-18, viral 70S RNA, and activated calf thymus DNA; 2) the degree of inhibition by fluoranthene derivatives was unaffected by the addition of the creased viral DNA polymerase; 3) with the same template, Escherichia coli DNA-directed RNA polymerase and the viral RNA-directed DNA polymerase were inhibited to about the same extent; and 4) the derivatives formed a complex with DNA, poly(I), and poly(A) that was stable to exclusion chromatography on Sephadex G-100. Several derivatives also had biologic activity, since they blocked the ability of the murine sarcoma virus to transform cells.
在浓度为7×10⁻⁶至7×10⁻⁵M时,由多环结构荧蒽、芴酮、芴、蒽醌、呫吨酮和二苯并呋喃与合适的胺侧链组成的衍生物,对禽成髓细胞瘤病毒纯化的依赖RNA的DNA聚合酶作用于聚(脱氧腺苷酸 - 脱氧胸苷酸)[聚(dA - dT)]的抑制率超过90%。其中,只有荧蒽衍生物是聚腺苷酸 - 寡聚脱氧胸苷酸[聚(A) - (dT)₁₂₋₁₈]指导的病毒DNA聚合酶的强抑制剂。低水平的荧蒽衍生物(1×10⁻⁵M)也强烈抑制以聚肌苷酸 - 寡聚脱氧胞苷酸[聚(I) - (dC)₁₂₋₁₈]、活化的小牛胸腺DNA和病毒70S RNA为模板的聚合酶,但对以聚胞苷酸 - 寡聚脱氧鸟苷酸为模板的聚合酶无抑制作用。对11种具有不同侧链的荧蒽衍生物的活性比较表明,胺侧链的结构既影响给定模板的抗聚合酶活性程度,也影响不同合成DNA和RNA模板的相对抑制作用。天然存在的多胺,精胺、亚精胺和腐胺,不抑制病毒DNA聚合酶的活性。作用机制研究表明,合成衍生物通过与模板而非酶结合来抑制聚合酶活性:1)加入过量模板包括聚(dA - dT)、聚(A) - (dT)₁₂₋₁₈、聚(I) - (dC)₁₂₋₁₈、病毒70S RNA和活化的小牛胸腺DNA可克服荧蒽衍生物的抑制作用;2)加入增加的病毒DNA聚合酶不影响荧蒽衍生物的抑制程度;3)以相同模板,大肠杆菌依赖DNA的RNA聚合酶和病毒依赖RNA的DNA聚合酶受到的抑制程度大致相同;4)这些衍生物与DNA、聚(I)和聚(A)形成复合物,该复合物在Sephadex G - 100上进行排阻色谱时稳定。几种衍生物也具有生物活性,因为它们阻断了鼠肉瘤病毒转化细胞的能力。